AwardedPOLGoods
Dostawa leku Mirvetuksymab sorawtanzyny.
- Published
- Published 27 April 2026
- Deadline
- Closed 11 May 2026
Overview
The Lublin Oncology Centre procured the supply of the pharmaceutical drug Mirvetuksymab sorwatanzyny. The contract was awarded to Abbvie Sp. z o.o. on 15 May 2026 for a value of 1,750,000 PLN.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Published
- 27 April 2026
- Deadline
- Closed
Various medicinal products
Award outcome
- Awarded value
- PLN 1,750,000
- Award date
- 15 May 2026
- Contract period
- — → 10 May 2027
- Abbvie Sp. z o.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
22 June 2026
Contract Notice
27 April 2026
Contracting authority
Centrum Onkologii Ziemi Lubelskiej im. św. Jana z Dukli
Procuring entityLublin, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.